U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H27N5O5S
Molecular Weight 461.535
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CIS-3'-GLIPIZIDE

SMILES

CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@@H]3CCC[C@H](O)C3

InChI

InChIKey=GZLIUWBDTXQVBY-SJORKVTESA-N
InChI=1S/C21H27N5O5S/c1-14-12-24-19(13-23-14)20(28)22-10-9-15-5-7-18(8-6-15)32(30,31)26-21(29)25-16-3-2-4-17(27)11-16/h5-8,12-13,16-17,27H,2-4,9-11H2,1H3,(H,22,28)(H2,25,26,29)/t16-,17+/m1/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
CIS-3'-GLIPIZIDE
Common Name English
2-PYRAZINECARBOXAMIDE, N-(2-(4-((((((1R,3S)-3-HYDROXYCYCLOHEXYL)AMINO)CARBONYL)AMINO)SULFONYL)PHENYL)ETHYL)-5-METHYL-, REL-
Systematic Name English
PYRAZINECARBOXAMIDE, N-(2-(4-((((((1R,3S)-3-HYDROXYCYCLOHEXYL)AMINO)CARBONYL)AMINO)SULFONYL)PHENYL)ETHYL)-5-METHYL-, REL-
Systematic Name English
Code System Code Type Description
CAS
38207-37-3
Created by admin on Sat Dec 16 14:23:02 UTC 2023 , Edited by admin on Sat Dec 16 14:23:02 UTC 2023
PRIMARY
PUBCHEM
156596469
Created by admin on Sat Dec 16 14:23:02 UTC 2023 , Edited by admin on Sat Dec 16 14:23:02 UTC 2023
PRIMARY
FDA UNII
UEX52WG4JB
Created by admin on Sat Dec 16 14:23:02 UTC 2023 , Edited by admin on Sat Dec 16 14:23:02 UTC 2023
PRIMARY